Neuromodulation Devices Stimulate Opportunities In Urology
Executive Summary
Neuromodulation for urological indications, notably overactive bladder (OAB), has been dominated since the late 1990s by Medtronic’s sacral-nerve stimulation system InterStim, with the more recent addition of Cogentix Medical’s Urgent PC for tibial nerve stimulation. Yet only a fraction of OAB patients receive effective neuromodulation treatment, and several companies hope to lower barriers to this modality by developing alternative devices for urological indications.
You may also be interested in...
People Briefs
Cogentix Medical appoints permanent president and CEO following proxy fight; TeraRecon announces CEO and new executives; Millar Names CEO; Novadaq founder tapped as CEO; and other recent executive moves in the medtech space.
Medtech Solutions For The "Other" Incontinence
Fecal incontinence is a common, devastating condition that often goes untreated. Eyeing the potential multibillion-dollar opportunity, medtech start-ups are developing approaches that range from small and disposable to surgical and permanent.
Medtronic Buys Bladder-Control Neurostimulation Firm
Medtronic plans to launch Advanced Uro-Solutions’ 510(k)-cleared Nuro percutaneous tibial nerve stimulation system in the next year following its Feb. 23 acquisition of the firm.